Primary Site >> Stomach Cancer
Gene >> SERPINE1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluid. PMID: 2852112 |
Ref: Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. PMID: 1636163 |
Ref: Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. PMID: 7903748 Ref: Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. PMID: 8187075 |
Ref: Surgical treatment of tumor metastases: general considerations and results. PMID: 7538364 Ref: Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. PMID: 7636552 Ref: Cysteine and serine proteases in gastric cancer. PMID: 8625115 Ref: The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer. PMID: 8852646 |
Ref: Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer. PMID: 8624578 Ref: Prognostic value of the plasminogen activation system in patients with gastric carcinoma. PMID: 8635120 Ref: Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations. PMID: 8658215 Ref: Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues. PMID: 8703368 Ref: The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancer. PMID: 8846873 Ref: Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. PMID: 9006092 Ref: Relationship between expression of plasminogen activator system and metastatic ability in human cancers. PMID: 21544336 Ref: Combined evaluation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression in gastric carcinoma. PMID: 21544388 |
Ref: High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. PMID: 9041148 Ref: Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role. PMID: 9219730 Ref: Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. PMID: 9409572 Ref: Prognostic factors in gastric cancer. PMID: 9448610 |
Ref: Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. PMID: 9502078 Ref: Diagnostic and prognostic values of plasma levels of fibrinolytic markers in gastric cancer. PMID: 9700849 Ref: Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer. PMID: 9794194 |
Ref: Immunohistochemical analysis of PAI-2 (plasminogen activator inhibitor type 2) and p53 protein in early gastric cancer patients with recurrence: a preliminary report. PMID: 10340041 Ref: Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer. PMID: 10402490 |
Ref: Activation of intercellular adhesion molecule 1 expression by Helicobacter pylori is regulated by NF-kappaB in gastric epithelial cancer cells. PMID: 10722567 Ref: c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. PMID: 10829039 Ref: Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs. PMID: 11448066 |
Ref: Gastric adenocarcinoma: pathomorphology and molecular pathology. PMID: 11315254 Ref: Pathogenicity island-dependent activation of Rho GTPases Rac1 and Cdc42 in Helicobacter pylori infection. PMID: 11401689 Ref: Helicobacter pylori: recent advances in the study of its pathogenicity and prevention. PMID: 11452701 Ref: Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer. PMID: 11489825 Ref: The cag Pathogenicity Island PMID: 21290735 |
Ref: Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. PMID: 11866445 Ref: Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. PMID: 11956259 |
Ref: Helicobacter pylori: resurrection of the cancer link. PMID: 12542550 Ref: [cag PAI and gastric carcinogenesis-association with p53 gene mutation]. PMID: 12607313 Ref: Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. PMID: 12708473 Ref: [Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer]. PMID: 12785198 Ref: Molecular mechanisms of carcinogenesis in gastric cancer. PMID: 12790321 Ref: Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer. PMID: 12888933 |
Ref: Persistence of gene expression changes in stomach mucosae induced by short-term N-methyl-N'-nitro-N-nitrosoguanidine treatment and their presence in stomach cancers. PMID: 15120970 Ref: Gastric epithelial cell CXC chemokine secretion following Helicobacter pylori infection in vitro. PMID: 15304113 |
Ref: Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. PMID: 16109653 Ref: Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. PMID: 16425389 |
Ref: Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens. PMID: 16435385 Ref: Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. PMID: 16630137 Ref: Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer? PMID: 17013798 |
Ref: Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. PMID: 17972143 Ref: Involvement of hypoxia-inducing factor-1alpha-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion. PMID: 18381294 Ref: Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. PMID: 18599586 Ref: PAI-1 expression levels in gastric cancers are closely correlated to those in corresponding normal tissues. PMID: 18795717 Ref: Association of Helicobacter pylori restriction endonuclease-replacing gene, hrgA with overt gastrointestinal diseases. PMID: 18852951 Ref: Analysis of NM23 protein and components of plasminogen activation system in tumors of patients with stomach cancer with consideration for disease clinical picture and morphology. PMID: 19513384 |
Ref: SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility. PMID: 20549826 Ref: Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. PMID: 20699000 |
Ref: PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability. PMID: 21216681 Ref: Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilian's patients: an association with histopathological parameters. PMID: 21470935 Ref: Pathogenicity island cag, vacA and IS605 genotypes in Mexican strains of Helicobacter pylori associated with peptic ulcers. PMID: 21569518 Ref: Gastric cancer: basic aspects. PMID: 21896084 Ref: Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1. PMID: 22015554 Ref: Positive selection on a bacterial oncoprotein associated with gastric cancer. PMID: 22078307 |
Ref: Plasminogen activator inhibitor 1 RNAi suppresses gastric cancer metastasis in vivo. PMID: 22098548 Ref: Gastric bezoar: a case of a patient treated with traditional Chinese medicine. PMID: 22268973 Ref: [Impact of hemocoagulase on coagulatory function and deep venous thrombosis after abdominal surgery]. PMID: 22539379 Ref: Genetic instability and CpG methylation in the 5'-flanking region of the PAI-1 gene in Chinese patients with gastric cancer. PMID: 22653645 Ref: Oral carcinogenesis is not achieved in different carcinogen-treated PAI-1 transgenic and wild-type mouse models. PMID: 23160684 |
Ref: Association between genetic polymorphisms of NOD 1 and Helicobacter pylori-induced gastric mucosal inflammation in healthy Korean population. PMID: 23136938 Ref: Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery. PMID: 23218127 |
Ref: Analysis of T4SS-induced signaling by H. pylori using quantitative phosphoproteomics. PMID: 25101063 Ref: miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1. PMID: 25170877 |
Ref: Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis. PMID: 25687870 Ref: Helicobacter pylori virulence factors in development of gastric carcinoma. PMID: 26346770 |
Ref: PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa. PMID: 27038741 Ref: Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis. PMID: 27313768 |
Ref: Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection. PMID: 28512631 |
Ref: Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis. PMID: 30065754 |